Matinas Biopharma Holdings Inc. (NYSE AMERICAN: MTNB)
$0.7099
+0.0099 ( +10.75% ) 12.9K
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
Market Data
Open
$0.7099
Previous close
$0.7000
Volume
12.9K
Market cap
$3.56M
Day range
$0.5910 - $0.6690
52 week range
$0.4780 - $21.5000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 68 | May 09, 2024 |
| 8-k | 8K-related | 20 | Apr 05, 2024 |
| 8-k | 8K-related | 43 | Mar 28, 2024 |
| 8-k | 8K-related | 15 | Mar 27, 2024 |
| 10-k | Annual reports | 89 | Mar 27, 2024 |
| 8-k | 8K-related | 17 | Mar 25, 2024 |
| 8-k | 8K-related | 15 | Mar 22, 2024 |
| 8-k | 8K-related | 15 | Mar 22, 2024 |
| 8-k | 8K-related | 16 | Feb 26, 2024 |
| 8-k | 8K-related | 16 | Feb 20, 2024 |